Our extensive experience in health technology assessment (HTA) through providing strategic advice and guiding evidence generation to support submissions to UK HTA bodies, enables us to provide you with a tailored solution to reimbursement and patient access.
Trends in Utility Values Applied in National Institute for Health and Care Excellence (NICE) Technology Appraisals for Non-Small Cell Lung Cancer (NSCLC).